BOD Recommends ₹10 Final Dividend for FY26; Approves Results

The Board of Directors of 539523 (Alkem Laboratories Limited) approved the standalone and consolidated audited financial results for Q4 and FY ended March 31, 2026. The Board recommended a final dividend of ₹10 per equity share (₹2 each) for FY26, subject to shareholder approval at the 52nd AGM on August 27, 2026. The record date for the dividend is August 7, 2026, with payment from September 1, 2026. Additionally, Mrs. Madhurima Singh's re-appointment as Executive Director for five years from December 20, 2026, was approved, subject to shareholder consent. The auditors expressed an unmodified opinion on the financial results.